Rasheda Persinger, NP-C, and Tiffany McFarlane, FNP-BC, discuss how biomarker testing guides mNSCLC treatment selection to ensure patients receive the most appropriate therapy for their lung cancer.
SupportingPatientsReceive
Supporting Patients to Receive the Appropriate Treatment for their Lung Cancer
0 Comments